title: Microglial chemotactic signaling factors in Alzheimer's disease.
abstract: The net migration of microglia induced by deposits of amyloid beta (Aβ) constitutes a chemotactic response of resident neuroimmune brain cells. This process serves to localize clusters of microglia nearby Aβ deposits preparatory to cellular activation and functional responses. Microglial responses to Aβ deposits localized in brain parenchyma and in blood vessels lead to acute and chronic neuroinflammation in Alzheimer's disease (AD) brain. This review summarizes studies on the prominent chemotactic factors MCP-1, MIP-1α and IL-8 and also includes recent work indicating VEGF and fractalkine as chemotactic agents. The possibility that microglial release of MCP-1 may play a role in mediating chemotactic responses of neural progenitor cells is also considered. The plethora of chemotactic factors and their cognate receptors suggests the utility in testing pharmacological modulation of chemotaxis for effects to inhibit chronic neuroinflammation and confer neuroprotection in AD animal models.
authors: Department of Anesthesiology, Pharmacology and Therapeutics, Faculty of Medicine, The University of British Columbia 2176 Health Sciences Mall, Vancouver, BC, Canada V6T 1Z3.
authors: James G
authors: JG
authors: McLarnon
keywords: AD animal models.; Alzheimer’s disease (AD); Chemotactic factors; inflammatory responses; microglial chemotaxis
references: Neurosci Lett. 2008 May 9;436(2):196-200
references: 18378084
references: Am J Pathol. 1998 Jan;152(1):307-17
references: 9422548
references: Am J Pathol. 1990 May;136(5):1101-14
references: 1693471
references: Nature. 2008 Feb 7;451(7179):720-4
references: 18256671
references: Neurobiol Aging. 2001 Nov-Dec;22(6):957-66
references: 11755004
references: J Biol Chem. 1996 Jan 12;271(2):603-6
references: 8557658
references: Psychiatry Clin Neurosci. 1997 Jun;51(3):135-8
references: 9225377
references: J Neuroimmunol. 2005 Feb;159(1-2):66-74
references: 15652404
references: Neurochem Int. 2001 Nov-Dec;39(5-6):333-40
references: 11578768
references: Arch Neurol. 2006 Apr;63(4):538-43
references: 16606766
references: Neurobiol Aging. 2002 Mar-Apr;23(2):237-43
references: 11804709
references: Neurobiol Aging. 2000 May-Jun;21(3):383-421
references: 10858586
references: J Neurosci. 2005 Sep 7;25(36):8240-9
references: 16148231
references: J Neuroinflammation. 2005 Oct 18;2:23
references: 16232318
references: Nat Med. 2006 Sep;12(9):1005-15
references: 16960575
references: Brain Pathol. 2009 Jul;19(3):392-8
references: 18637012
references: Neurobiol Aging. 2004 May-Jun;25(5):675-83
references: 15172747
references: Trends Neurosci. 1996 Aug;19(8):312-8
references: 8843599
references: J Immunol. 1996 Aug 1;157(3):1213-8
references: 8757628
references: J Neurovirol. 1999 Feb;5(1):32-41
references: 10190688
references: Int J Alzheimers Dis. 2012;2012:345472
references: 22919540
references: Neurobiol Aging. 2001 Nov-Dec;22(6):945-56
references: 11755003
references: Physiol Rev. 2011 Apr;91(2):461-553
references: 21527731
references: Eur J Cell Biol. 2004 Aug;83(8):381-7
references: 15506562
references: Am J Pathol. 2005 May;166(5):1475-85
references: 15855647
references: Am J Pathol. 1998 Jul;153(1):31-7
references: 9665462
references: J Neurosci. 2009 Jan 7;29(1):3-13
references: 19129379
references: Brain Res Mol Brain Res. 1998 Nov 12;62(1):101-5
references: 9795165
references: Glia. 2002 Nov;40(2):260-9
references: 12379913
references: Neurochem Res. 2008 Jun;33(6):1085-9
references: 18095157
references: J Neuroimmunol. 2002 Nov;132(1-2):93-8
references: 12417438
references: Glia. 2001 Jul;35(1):72-9
references: 11424194
references: J Neuroinflammation. 2009 Dec 23;6:39
references: 20030829